Peristaltic Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

The peristaltic pumps market is expected to register a CAGR of 6.1% during the forecast period.

The pharmaceutical and medical end-use industries drove the demand for peristaltic pumps while producing the COVID-19 vaccine. A peristaltic pump is ideal for preparing viral transport medium (VTM) tubes for COVID-19 testing as it can aliquot medium into individual, sterile screw-capped tubes quickly and efficiently. The pump's enclosed liquid system, easily sterilizable tubing, and lack of valves or seals reduce the risk of contamination to the product and the pump itself. Growing initiatives from key market players further drove the market during the pandemic. For instance, in September 2021, the US lab products provider Avantor planned to buy Masterflex from privately held Antylia Scientific to increase its COVID-19 therapy and vaccine manufacturing operations. Masterflex manufactures products like peristaltic pumps used to research and produce biological drugs, vaccines, and cell and gene therapies. Such initiatives also drove the market during the pandemic. Currently, the market is losing traction, with the number of COVID-19 cases declining. However, it is expected to have stable growth during the forecast period.

Rising investments in expanding water wastewater treatment plants worldwide and increasing investments in drug development and discovery are boosting the market's growth.

The rising importance of peristaltic pumps in the pharmaceutical and biopharmaceutical industries is expected to drive the market. For instance, according to the study published in LabOnline in October 2021, peristaltic pumps offer a versatile solution to reduce cleaning requirements while preventing product contamination and facilitating equipment reconfiguration between batches. Thus, such benefits of peristaltic pumps in the preparation of formulation are anticipated to boost their demand in the pharmaceutical industry.

Increasing investments in drug development and discovery are anticipated to drive the market over the forecast period. Peristaltic pumps are used in the pharmaceutical and medical industries to make biological and medicinal products, process botanical drugs and herbs, isolate active medicinal principles, and make pharmaceutical products for internal and external consumption in various forms. According to a report published in September 2021 by the Pharmaceutical Research and Manufacturers of America (PhRMA), biopharmaceutical companies invested more than a trillion dollars in R&D in the last decade. Such substantial R&D investments are anticipated to drive the market's growth due to the rising adoption of peristaltic pumps in biopharma industries.

Various strategies adopted by key market players may drive the market over the projected period, such as product launches, mergers, and acquisitions. For instance, in August 2021, Watson-Marlow Fluid Technology Group (WMFTG) launched the next generation of its industry-leading Qdos chemical metering pumps. Qdos Conveying Wave Technology (CWT) enhanced peristaltic pump capabilities by providing a longer service life than traditional tube-based designs. Such launches are expected to propel the market's growth.

However, frequent replacement of hoses and tubes may restrain the market over the forecast period.

Key Market Trends

Peristaltic Tube Pumps Segment is Expected to Hold Significant Market Share of the Peristaltic Pumps Market

Peristaltic tube pumps have flexible tubes that use positive displacement to transport fluids in a continuous, smooth pulsing motion, simulating natural peristalsis found in many biological systems. These are used to dispense fluid in a variety of applications, including pharmaceuticals, food, cosmetics, chemicals, and construction. As a result, the growing demand for peristaltic tube pumps is expected to drive the segment.

The rising initiatives from key market players for the display of peristaltic tube pumps are expected to bolster the market’s growth. For instance, in October 2021, DuPont showcased the new DuPont Liveo Pharma TPE Tubing at three industry events, including CBioPC in Nanjing, China, INTERPHEX in New York, United States, and CPhI in Milan, Italy. Such exhibitions are expected to drive the segment due to increased product awareness.

According to the study published in the Journal of Mechanical Behaviour of Biomedical Materials in December 2022, peristaltic tubing pump is very frequently used in hospitals or drug production and has versatile applications. Such applications and increased adoption are anticipated to drive the segment.

Thus, all such factors are expected to boost the segment’s growth over the forecast period.

North America Holds a Significant Share and is Expected to Continue the Trend During the Forecast Period

North America may hold a significant share in the peristaltic pump market during the forecast period due to the presence of many academic and research institutes, diagnostic labs, diagnostic centers, and pharmaceutical companies that use peristaltic pumps in disinfection applications, propelling the regional market.

According to the 2022 PhRMA Annual Membership Survey, the R&D expenditure of PhRMA Member Companies in the United States was USD 79,610.0 million in 2021, up by 9.9% from the previous year. According to the Canadian government, CAD 922.9 million was spent as a total R&D expenditure by patentees, an increase of 12.2% over the previous year, and CAD 735.9 million was spent in R&D expenditures as reported by Innovative Medicines Canada members, an increase of 11.0% over the previous year. Such huge R&D expenditures by the pharma and biopharma companies in the North American region are expected to drive the segment due to the rising adoption of peristaltic pumps in drug discovery.

Key strategies by market players, such as product launches, mergers and acquisitions, and expansions, are expected to drive the market over the forecast period. In April 2022, NETZSCH Pumps North America LLC entered the peristaltic market with the launch of the PERIPRO Pump and expanded its positive displacement pump offerings. The pump delivers low and large flow rates at various pressures.

Thus, all such factors are expected to boost the market’s growth in the region over the forecast period.

Competitive Landscape

The peristaltic pump market is moderately fragmented. Market players are focusing on product innovations, new product launches, and regional expansions to increase their market share. Some of the market players operating in the peristaltic pump market are Cole-Parmer Instrument Company LLC, Capillary Oy (Flowrox Oy), Gilson Inc., IDEX Corporation, Prominent Systems Inc., Randolph Austin Company, Graco Inc., and Verder Group.

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.